ClinicalTrials.Veeva

Menu

Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients (COOBrA)

T

Toulouse University Hospital

Status

Completed

Conditions

Acute Kidney Injury

Treatments

Other: Collection of clinical and biological data during renal replacement therapy sessions

Study type

Observational

Funder types

Other

Identifiers

NCT04444765
RC31/19/0496

Details and patient eligibility

About

Acute kidney injury (AKI) affects up to 30% of critically ill patients and is associated with increased rates of mortality. Up to 60% of patients with AKI will ultimately require renal replacement therapy (RRT). Intermittent hemodialysis (IHD) is one of the main methods of RRT worldwide. In IHD-bicar, dialysate is composed by electrolytes, including calcium, and bicarbonate. To avoid calcium carbonate precipitation, dialysate has to be supplemented with acids (citric acid, chloride acid or acetic acid). However, IHD-bicar may be associated with hemodynamic instability or respiratory intolerance, mainly related to the CO2 release in the circulation during IHD (HCO3- <--> CO2 + H2O). Some recent studies showed that acetate free biofiltration (AFB-K), a technique that does not require dialysate acidification, could be associated with better hemodynamic stability and to a lower amount of CO2 delivered to the patients. AFB-K may thus improve the hemodynamic and respiratory tolerance of intermittent RRT in critically ill patients.

Full description

In this prospective observational study, investigators aim to characterize the hemodynamic and respiratory tolerances of HDI-bicar and AFB-K in critically ill patients requiring RRT.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥ 18 years old
  • Invasive monitoring of blood pressure
  • Non opposition to the research
  • Admission to the intensive care unit
  • Need of intermittent hemodialysis

Exclusion criteria

  • Sodium bicarbonate infusion
  • Pregnancy or breastfeeding
  • Juridical protection

Trial design

200 participants in 2 patient groups

Patients with bicarbonate-based intermittent dialysis
Description:
Dialysate is composed by electrolytes, including calcium, and bicarbonate. To avoid calcium carbonate precipitation, dialysate has to be supplemented with acids (citric acid, chloride acid or acetic acid).
Treatment:
Other: Collection of clinical and biological data during renal replacement therapy sessions
Patients with acetate free biofiltration dialysis
Description:
Acetate free biofiltration (AFB-K)is a technique that does not require dialysate acidification
Treatment:
Other: Collection of clinical and biological data during renal replacement therapy sessions

Trial contacts and locations

1

Loading...

Central trial contact

Stanislas Faguer, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems